Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy

BACKGROUND: Most thalassemic patients with chronic hepatitis C virus (HCV) infection do not respond to therapy with pegylated interferon (Peg-IFN) plus ribavirin (RBV) due to hepatic siderosis and RBV dose reduction caused by RBV-induced anemia. OBJECTIVES: In the present study, we recruited HCV gen...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hepat Mon
Hlavní autoři: Sandoughdaran, Saleh, Alavian, Seyed Moayed, Sharafi, Heidar, Behnava, Bita, Salimi, Shima, Mehrnoush, Leila, Karimi Elizee, Pegah, Keshvari, Maryam
Médium: Artigo
Jazyk:Inglês
Vydáno: Kowsar 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4344648/
https://ncbi.nlm.nih.gov/pubmed/25741371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.23564
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky